BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

954 related articles for article (PubMed ID: 26668027)

  • 1. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
    Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.
    Büscher AK; Kranz B; Büscher R; Hildebrandt F; Dworniczak B; Pennekamp P; Kuwertz-Bröking E; Wingen AM; John U; Kemper M; Monnens L; Hoyer PF; Weber S; Konrad M
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):2075-84. PubMed ID: 20798252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid-resistant nephrotic syndrome: impact of genetic testing.
    Kari JA; El-Desoky SM; Gari M; Malik K; Vega-Warner V; Lovric S; Bockenhauer D
    Ann Saudi Med; 2013; 33(6):533-8. PubMed ID: 24413855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Bierzynska A; McCarthy HJ; Soderquest K; Sen ES; Colby E; Ding WY; Nabhan MM; Kerecuk L; Hegde S; Hughes D; Marks S; Feather S; Jones C; Webb NJ; Ognjanovic M; Christian M; Gilbert RD; Sinha MD; Lord GM; Simpson M; Koziell AB; Welsh GI; Saleem MA
    Kidney Int; 2017 Apr; 91(4):937-947. PubMed ID: 28117080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
    Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
    Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible.
    Klaassen I; Özgören B; Sadowski CE; Möller K; van Husen M; Lehnhardt A; Timmermann K; Freudenberg F; Helmchen U; Oh J; Kemper MJ
    Pediatr Nephrol; 2015 Sep; 30(9):1477-83. PubMed ID: 25903641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
    Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
    Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
    Trautmann A; Bodria M; Ozaltin F; Gheisari A; Melk A; Azocar M; Anarat A; Caliskan S; Emma F; Gellermann J; Oh J; Baskin E; Ksiazek J; Remuzzi G; Erdogan O; Akman S; Dusek J; Davitaia T; Özkaya O; Papachristou F; Firszt-Adamczyk A; Urasinski T; Testa S; Krmar RT; Hyla-Klekot L; Pasini A; Özcakar ZB; Sallay P; Cakar N; Galanti M; Terzic J; Aoun B; Caldas Afonso A; Szymanik-Grzelak H; Lipska BS; Schnaidt S; Schaefer F;
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):592-600. PubMed ID: 25635037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.
    Suvanto M; Patrakka J; Jahnukainen T; Sjöström PM; Nuutinen M; Arikoski P; Kataja J; Kestilä M; Jalanko H
    Clin Exp Nephrol; 2017 Aug; 21(4):677-684. PubMed ID: 27573339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2).
    Hinkes BG; Mucha B; Vlangos CN; Gbadegesin R; Liu J; Hasselbacher K; Hangan D; Ozaltin F; Zenker M; Hildebrandt F;
    Pediatrics; 2007 Apr; 119(4):e907-19. PubMed ID: 17371932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.
    Ruf RG; Lichtenberger A; Karle SM; Haas JP; Anacleto FE; Schultheiss M; Zalewski I; Imm A; Ruf EM; Mucha B; Bagga A; Neuhaus T; Fuchshuber A; Bakkaloglu A; Hildebrandt F;
    J Am Soc Nephrol; 2004 Mar; 15(3):722-32. PubMed ID: 14978175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causal and putative pathogenic mutations identified in 39% of children with primary steroid-resistant nephrotic syndrome in South Africa.
    Nandlal L; Winkler CA; Bhimma R; Cho S; Nelson GW; Haripershad S; Naicker T
    Eur J Pediatr; 2022 Oct; 181(10):3595-3606. PubMed ID: 35920919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome.
    Wang F; Zhang Y; Mao J; Yu Z; Yi Z; Yu L; Sun J; Wei X; Ding F; Zhang H; Xiao H; Yao Y; Tan W; Lovric S; Ding J; Hildebrandt F
    Pediatr Nephrol; 2017 Jul; 32(7):1181-1192. PubMed ID: 28204945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.
    Santín S; Bullich G; Tazón-Vega B; García-Maset R; Giménez I; Silva I; Ruíz P; Ballarín J; Torra R; Ars E
    Clin J Am Soc Nephrol; 2011 May; 6(5):1139-48. PubMed ID: 21415313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of novel genetic variation in NPHS2 gene associated with idiopathic nephrotic syndrome in South Indian children.
    Dhandapani MC; Venkatesan V; Rengaswamy NB; Gowrishankar K; Ekambaram S; Sengutavan P; Perumal V
    Clin Exp Nephrol; 2017 Feb; 21(1):127-133. PubMed ID: 26820844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome.
    Gbadegesin R; Hinkes B; Vlangos C; Mucha B; Liu J; Hopcian J; Hildebrandt F
    Pediatr Nephrol; 2007 Apr; 22(4):509-13. PubMed ID: 17216259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
    Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPHS2 mutations account for only 15% of nephrotic syndrome cases.
    Guaragna MS; Lutaif AC; Piveta CS; Souza ML; de Souza SR; Henriques TB; Maciel-Guerra AT; Belangero VM; Guerra-Junior G; De Mello MP
    BMC Med Genet; 2015 Sep; 16():88. PubMed ID: 26420286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of podocyte genes in children with sporadic steroid-resistant nephrotic syndrome.
    Feng DN; Yang YH; Wang DJ; Meng DC; Fu R; Wang JJ; Yu ZH
    Genet Mol Res; 2014 Nov; 13(4):9514-22. PubMed ID: 25501161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.